Patty Murray: Trump Administration Declared 'War on Public Health' by Cutting NIH Grants
Forbes Breaking NewsNovember 7, 20255 min1,861 views
19 connectionsΒ·24 entities in this videoβTrump Administration's Impact on NIH and Public Health
- π Since President Trump took office, the administration has terminated $2.3 billion in life-saving research funded by the NIH.
- π° They attempted to cut billions more by illegally implementing a new indirect cost policy and proposed gutting the NIH budget by 43% ($20 billion).
- π¬ Thousands of scientists and grant administrators have been laid off across NIH and HHS, and the FDA's review of drugs and medical products has been slowed due to staff reductions.
- β οΈ Over 100 clinical trials discovering new treatments and cures have been halted, leading Senator Murray to declare the administration has declared 'war on public health'.
Decreased Competitiveness in Biomedical Research
- π Cancelling over 5,000 NIH grants, from cancer to Alzheimer's, substantially decreases American competitiveness in biomedical research and innovation.
- π Without continued support, the U.S. risks losing the competitive battle with research institutions in other countries, impacting the development of cures and spin-off companies.
- π‘ More than 99% of new drugs approved by the FDA from 2010-2019 were built on a foundation of NIH-funded research, highlighting its critical role.
Consequences for Pharmaceutical Companies and Patients
- β³ Short-term, cancelled clinical trials and delayed grant awards mean that potentially safe and effective therapies are not reaching patients in a timely manner.
- π Long-term, cuts to NIH mean a lack of foundational research, which is the catalyst for innovation and the development of transformative treatments in 5-10 years.
- π Biotech industries lack the resources and short-term focus to replace NIH funding, as they prioritize 1-5 year returns for shareholders.
Impact on Rare Disease Patients and Trainees
- π Cancelling rare disease clinical trials and suspending future funding directly impacts rare disease patients and their families, disrupting the virtuous circle of innovation.
- π Trainees are leaving the U.S. for other countries due to a lack of research opportunities in public, academic, and private sectors, exacerbated by huge job cuts.
- ποΈ Congress has a responsibility to fund critical agencies like NIH and FDA, rather than decimating the future through layoffs, firings, and funding cuts.
Knowledge graph24 entities Β· 19 connections
How they connect
An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.
Hover Β· drag to explore
24 entities
Chapters3 moments
Key Moments
Transcript22 segments
Full Transcript
Topics13 themes
Whatβs Discussed
NIH GrantsTrump AdministrationPublic HealthBiomedical ResearchNIH Budget CutsFDAClinical TrialsRare DiseasesPharmaceutical CompaniesMedical InnovationAmerican CompetitivenessScientific Research FundingBiotechnology Industry
Smart Objects24 Β· 19 links
CompaniesΒ· 8
ConceptsΒ· 4
MediasΒ· 8
PeopleΒ· 2
LocationΒ· 1
EventΒ· 1